Mar 28 |
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
|
Mar 28 |
Pulse Biosciences Announces Plans to Initiate a Rights Offering
|
Mar 28 |
Earnings Scheduled For March 28, 2024
|
Mar 14 |
Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024
|
Mar 8 |
Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
|
Feb 14 |
Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
|
Feb 2 |
Companies Like Pulse Biosciences (NASDAQ:PLSE) Are In A Position To Invest In Growth
|
Jan 31 |
Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium
|
Jan 6 |
Insiders of Pulse Biosciences, Inc. (NASDAQ:PLSE) must be disappointed as stock fell 26% after recent purchases
|
Jan 2 |
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday
|